News & Updates
Filter by Specialty:
Hypertension-related CVD rates rise from 1990 to 2019
For three decades, hypertension-related cardiovascular disease (CVD) burden in young adults has substantially rose, with spatiotemporal and sexual heterogeneity, according to a study. Middle-income countries bear the heaviest burden, particularly men.
Hypertension-related CVD rates rise from 1990 to 2019
23 Nov 2021
Exercise SBP tied to cardiovascular disease risk
Exercise systolic blood pressure (SBP) is linked to several cardiovascular risk factors, which tend to be worse in individuals with a hypertensive response to exercise (HRE), reveals a study.
Exercise SBP tied to cardiovascular disease risk
23 Nov 2021
Guselkumab yields durable benefit in biologic-naïve PsA patients
The interleukin (IL)-23p19-subunit inhibitor guselkumab appears to produce improvements in multiple disease domains of psoriatic arthritis (PsA) with no unexpected safety findings through 2 years of treatment in biologic-naïve patients, according to the phase III DISCOVER-2 trial.
Guselkumab yields durable benefit in biologic-naïve PsA patients
23 Nov 2021
High acute-to-chronic glycaemic ratio tied to worse prognosis in T2D patients with COVID-19
Type 2 diabetes (T2D) patients with COVID-19 who have elevated acute-to-chronic (A/C) glycaemic ratio are at increased risk of adverse outcomes, including in-hospital mortality, intensive care unit (ICU) admission, and mechanical ventilation, a study has found.
High acute-to-chronic glycaemic ratio tied to worse prognosis in T2D patients with COVID-19
23 Nov 2021
6 months of adjuvant trastuzumab noninferior to 12 months in HER2-positive early breast cancer
Six months of adjuvant trastuzumab treatment is noninferior to the standard of care (SoC) of 12 months in patients with HER2-positive early-stage breast cancer, according to results from an individual patient data (IPD) meta-analysis of five noninferiority randomized controlled trials (RCTs) presented at the European Society for Medical Oncology (ESMO) Congress 2021.